Valeant annual report reveals new issues, company overhauls board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Grand Canyon Education places CFO on leave amid stock trade probe
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- Funds sell $44bn in semiconductors on AI concerns
BMO Capital 'Incrementally Positive' on Valeant (VRX) 10K, But Notes Important Changes in Fundamentals
April 29, 2016 11:23 AM EDTBMO Capital analyst Alex Arfaei weighed in Valeant Pharmaceuticals (NYSE: VRX) after the 10K. He said it was incrementally positive, although notes important change in fundamentals.
Arfaei commented, "Valeant is now in compliance of its debt agreements, and should avert technical default on its debt. As far as we can tell, the new restatement is related to 4Q15, and it is modest. 4Q15 revenue is now $21MM lower because of Addyi and Xifaxan adjustments, this brings non-GAAP EPS down from $2.50 to $2.40 under the... More
Valeant Pharma (VRX) Resumes Trading
April 29, 2016 9:50 AM EDTValeant Pharma (NYSE: VRX) shares resume trading. The stock was up around 2 percent, but is now about flat.
... MoreValeant Pharma (VRX) Announces Nominees For Election to Board
April 29, 2016 9:33 AM EDTValeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the nominees for election to its Board of Directors at the 2016 Annual Meeting of Shareholders on June 14, 2016.
As announced on April 25, 2016, Joseph C. Papa has been named Valeant's Chairman and Chief Executive Officer. Mr. Papa has been nominated for election to the Board, along with Robert A. Ingram, Robert N. Power and five of the current independent directors who were appointed to the Board in the last year: William A. Ackman, Dr. Frederic Eshelman, Stephen... More
